Company record
Cipla Limited
1 FDA warning letter since 2023 and 1 recall in the last 12 months.
Get an email the day FDA posts anything new about Cipla Limited.
Warning letters
-
DrugsCipla Limited
FDA warned Cipla about unresolved albuterol inhaler delivery complaints and contamination in sterile manufacturing at its Indore site.
High risk
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Dec 10, 2025 | Class II | Cipla Limited Drug |
Phytonadione Injectable Emulsion, USP 10mg/mL, 10x1 mL Single-Dose Vial/carton, Rx Only, Mfd. by: Cipla Ltd. India At M/s Immacule Lifesciences PVT. Ltd. India. Mfd. for: Cipla USA, Inc. Warren, NJ 07059. Vial NDC# 69097… Failed Stability Specifications: Observed OOS results: eg results for colour index |